Betulinic Acid Market Global Report 2026

The betulinic acid market size has grown rapidly in recent years. It will grow from $1.45 billion in 2025 to $1.64 billion in 2026 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to traditional use of plant-derived compounds in herbal medicine systems, growing pharmaceutical interest in natural product screening, increasing prevalence of chronic diseases driving drug discovery research, expansion of botanical extraction technologies, rising academic research in triterpenoid chemistry.

The betulinic acid market size is expected to see rapid growth in the next few years. It will grow to $2.69 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to expansion of precision medicine and targeted cancer therapies, increasing investment in natural compound-based drug development, growth in antiviral and immunotherapy research, rising demand for bioactive nutraceutical ingredients, advancements in synthetic biology and compound optimization techniques. Major trends in the forecast period include increased research on betulinic acid as a potential anticancer and antiviral therapeutic compound, growing use of plant-derived triterpenoids in pharmaceutical drug discovery pipelines, expansion of natural bioactive compounds in nutraceutical formulations, rising adoption of botanical extracts in dermatology and cosmetic anti-inflammatory products, increasing focus on semi-synthetic modification of betulinic acid for enhanced bioavailability and efficacy.

The increasing research and development spending in pharmaceutical drug discovery is expected to propel the growth of the betulinic acid market going forward. Research and development spending in pharmaceutical drug discovery refers to financial investments made by companies and institutions to develop new drugs, therapies, and treatment solutions. The increase in research and development spending in pharmaceutical drug discovery is driven by growing demand for advanced and targeted therapies, which is accelerating innovation in drug development. Research and development spending related to betulinic acid is utilized to optimize its chemical properties, improve bioavailability, and validate its safety and efficacy for applications such as anticancer and antiviral therapies. For instance, in January 2024, according to Food and Drug Administration, a US-based government agency, 55 novel drugs were approved in 2023 compared to 37 in 2022, with 36% classified as first-in-class therapies and more than 50% targeting rare diseases. Therefore, the increasing research and development spending in pharmaceutical drug discovery is driving the growth of the betulinic acid market.

The increasing prevalence of cancer is expected to propel the growth of the betulinic acid market going forward. Cancer refers to a group of diseases characterized by uncontrolled cell growth that can spread to other parts of the body and require therapeutic intervention. The increasing prevalence of cancer is driven by the growing aging population, which is contributing to higher incidence rates globally. Betulinic acid supports this demand by offering potential anticancer properties that contribute to the research and development of novel therapeutic treatments. For instance, in October 2025, according to Cancer Research UK, a UK-based independent cancer research organization, cancer incidence in the UK is projected to grow by approximately 2% between 2024-2026 and 2038-2040, reaching more than 505,000 new cases annually by the end of the forecast period. Therefore, the increasing prevalence of cancer is driving the growth of the betulinic acid market.

The growing use in cosmetics and skincare is expected to propel the growth of the betulinic acid market going forward. Cosmetics and skincare refer to products designed for cleansing, protecting, and enhancing the appearance and health of the skin through active ingredients and formulations. The increasing demand for natural and plant-based skincare products, driven by rising consumer awareness regarding clean-label ingredients and skin health, is accelerating the adoption of bioactive compounds in formulations. Betulinic acid supports this demand by offering anti-inflammatory, antioxidant, and skin-repair properties, making it a valuable ingredient in anti-aging creams, serums, and dermatological products. For instance, in June 2025, according to Cosmetic, Toiletry and Perfumery Association, a UK-based trade association, in 2024, the toiletries and beauty sector recorded sales of $13.9 billion (£10.3 billion), reflecting robust year-on-year growth of 8.4%. Therefore, the growing use in cosmetics and skincare is driving the growth of the betulinic acid market.

Major companies operating in the betulinic acid market are Symrise BioActives GmbH, Purestar Chem Enterprise Co. Ltd., Cayman Chemical, Tokyo Chemical Industry Co. Ltd., Santa Cruz Biotechnology Inc., MedChemExpress, Leap Chem Co. Ltd., H&Z Industry Co. Ltd., Finetech Industry Limited, Aktin Chemicals Inc., BOC Sciences, Manus Aktteva Biopharma LLP, Hangzhou Lingrui Chemical Co. Ltd., Capot Chemical Co. Ltd., Kono Chem Co. Ltd., Glentham Life Sciences Ltd., Xiamen Hisunny Chemical Co. Ltd., Dayang Chem (Hangzhou) Co. Ltd., BIOZOL Diagnostica Vertrieb GmbH, Wuhan PharmChem Co. Ltd., Betulin Lab, Shanghai Tauto Biotech Co. Ltd., DaXingAnLing Lingonberry Boreal Biotech, Simagchem Corporation, Sancai Industry Co. Ltd.

North America was the largest region in the betulinic acid market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the betulinic acid market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the betulinic acid market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The betulinic acid market consists of sales of naturally derived triterpenoid compounds, purified extracts, and formulated products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.